258 related articles for article (PubMed ID: 31399165)
1. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation.
Sureshkumar KK; Chopra B
Transplant Proc; 2019; 51(6):1796-1800. PubMed ID: 31399165
[TBL] [Abstract][Full Text] [Related]
2. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
3. Human Leukocyte Antigen Mismatch and Steroid Maintenance in Kidney Transplantation.
Chopra B; Sureshkumar KK
Transplant Proc; 2015 Dec; 47(10):2852-4. PubMed ID: 26707301
[TBL] [Abstract][Full Text] [Related]
4. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
5. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
Bunnapradist S; Hong A; Lee B; Takemoto SK
Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
[TBL] [Abstract][Full Text] [Related]
7. A new HLA allocation procedure of kidneys from deceased donors in the current era of immunosuppression.
Broeders N; Racapé J; Hamade A; Massart A; Hoang AD; Mikhalski D; Le Moine A; Vereerstraeten P
Transplant Proc; 2015 Mar; 47(2):267-74. PubMed ID: 25769559
[TBL] [Abstract][Full Text] [Related]
8. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
9. Does Induction Type Influence Outcomes in Kidney Transplant Recipients at Different Phases of Hepatitis B Infection?
Sureshkumar KK; Chopra B
Exp Clin Transplant; 2019 Aug; 17(4):457-460. PubMed ID: 30066624
[TBL] [Abstract][Full Text] [Related]
10. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
[TBL] [Abstract][Full Text] [Related]
11. Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Opelz G; Döhler B
Transplantation; 2011 Jan; 91(1):65-9. PubMed ID: 21452411
[TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen-DR mismatch status on kidney graft survival in a predominantly African-American population under the newer immunosuppressive era.
Karabicak I; Adekile A; Distant DA; O'Shaunessy D; Lewis S; Sumrani NB; Norin AJ; Salifu MO
Transplant Proc; 2011 Jun; 43(5):1544-50. PubMed ID: 21693232
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
[TBL] [Abstract][Full Text] [Related]
14. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
Cai J; Terasaki PI
Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
[TBL] [Abstract][Full Text] [Related]
15. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
Sureshkumar KK; Hussain SM; Nashar K; Marcus RJ
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):741-9. PubMed ID: 24969182
[TBL] [Abstract][Full Text] [Related]
16. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Aguilar-Sandoval E; De la Paz-Román M; Soto-Miranda E; Rivera-Sanchez Y; Martínez-Maldonado M
Transplant Proc; 2021 Apr; 53(3):1005-1009. PubMed ID: 32178925
[TBL] [Abstract][Full Text] [Related]
17. HLA gene dosage effect on renal allograft survival.
Kim KH; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Transplant Proc; 2015 Apr; 47(3):635-9. PubMed ID: 25891701
[TBL] [Abstract][Full Text] [Related]
18. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.
Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M
Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198
[TBL] [Abstract][Full Text] [Related]
19. Tailored immunosuppression after kidney transplantation - a single center real-life experience.
Good-Weber M; Roos M; Mueller TF; Rüsi B; Fehr T
BMC Nephrol; 2020 Nov; 21(1):501. PubMed ID: 33228545
[TBL] [Abstract][Full Text] [Related]
20. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
